Inhibition of lysosomal cysteine proteases by chrysotherapeutic compounds: a possible mechanism for the antiarthritic activity of Au(I)

Bioorganic & Medicinal Chemistry Letters
Aida Chircorian, Amy M Barrios

Abstract

Although Au(I) complexes have been used to treat rheumatoid arthritis for over 75 years, their mechanism of action is still poorly understood. A family of enzymes responsible for joint destruction in rheumatoid arthritis, the cathepsins, has been discussed as a possible biological target of Au(I). In this study, inhibition of the cathepsins by known Au(I) drugs and related compounds was investigated. The compounds tested inhibited cathepsin activity with IC50 values as low as 600 nM. More typical IC50 values were in the 50-200 microM range. Although the gold complexes are not extremely potent cathepsin inhibitors, it is likely that this inhibition is biologically relevant given the high concentrations of Au(I) in the serum and joints of patients undergoing chrysotherapy. While it is likely that there are multiple targets of Au(I) in vivo, inhibition of the cathepsins would provide protection against the joint destruction that is a hallmark of rheumatoid arthritis and is one possible mechanism for Au(I) antiarthritic activity.

References

Aug 1, 1987·Seminars in Arthritis and Rheumatism·R M SnyderS T Crooke
Jan 1, 1986·Journal of Clinical Pharmacology·D G Baker, J L Rabinowitz
Oct 25, 1985·The Medical Letter on Drugs and Therapeutics
Nov 1, 1972·Journal of Medicinal Chemistry·B M SuttonM J DiMartino
Jan 1, 1968·Acta Rheumatologica Scandinavica·S Paltemaa
May 1, 1983·British Journal of Pharmacology·D Rohozková, F S Steven
Apr 1, 1980·Agents and Actions·A J LewisD H Brown
May 1, 1996·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·T J HallM Schaeublin
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·K I JeonD M Jue
Dec 12, 2001·JAMA : the Journal of the American Medical Association·D S Pisetsky, E W St Clair
Dec 26, 2001·Chemical Reviews·C F Shaw III
Aug 7, 2002·British Journal of Pharmacology·Maria Pia RigobelloAlberto Bindoli
Nov 26, 2002·The Journal of Biological Chemistry·Jivko V Stoyanov, Nigel L Brown
May 20, 2003·Experimental & Molecular Medicine·Kye-Im JeonDae-Myung Jue

❮ Previous
Next ❯

Citations

Sep 1, 2009·Metallomics : Integrated Biometal Science·Pascaline Fonteh, Debra Meyer
Dec 22, 2009·Dalton Transactions : an International Journal of Inorganic Chemistry·John SpencerPaul J Dyson
Nov 13, 2010·Metallomics : Integrated Biometal Science·Simon P Fricker
May 25, 2010·Dalton Transactions : an International Journal of Inorganic Chemistry·Alex John, Prasenjit Ghosh
Feb 16, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Krishna P BhabakGovindasamy Mugesh
Mar 2, 2011·Metallomics : Integrated Biometal Science·John SpencerMatthew Guille
Jul 15, 2011·Metallomics : Integrated Biometal Science·Susan J Berners-Price, Aleksandra Filipovska
Dec 15, 2010·Antimicrobial Agents and Chemotherapy·Zachary L NewmanLisa M Johansen
Aug 25, 2009·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Felicia SuskaPeter Thomsen
Jul 23, 2005·Free Radical Research·Maria Pia RigobelloAlberto Bindoli
Jan 1, 2008·Journal of Inorganic Biochemistry·Shamila S Gunatilleke, Amy M Barrios
Jan 8, 2008·Journal of Inorganic Biochemistry·Angela CasiniLuigi Messori
Feb 7, 2008·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Shamila S GunatillekeAmy M Barrios
Nov 16, 2017·PloS One·Gopinath VenugopalSvenja Steinfelder
Oct 16, 2019·Molecular Neurobiology·Natalia Dos Santos TramontinAlexandre Pastoris Muller
Oct 8, 2019·Current Medicinal Chemistry·Xiaoyuan RenArne Holmgren
Apr 17, 2012·Dalton Transactions : an International Journal of Inorganic Chemistry·Biljana Đ GlišićMiloš I Djuran
Aug 1, 2012·Angewandte Chemie·Andreas MeyerIngo Ott
Aug 30, 2012·Dalton Transactions : an International Journal of Inorganic Chemistry·Declan Gaynor, Darren M Griffith
Apr 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Michael B HarbutFeng Wang
Mar 10, 2018·Current Medicinal Chemistry·Andrea Erxleben
Dec 14, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chiau-Yuang TsaiHuan-Yao Lei
Feb 9, 2021·Acta Parasitologica·Iman Fathy Abou-El-Naga, Nermine Mogahed Fawzy Hussein Mogahed
Apr 23, 2008·Inorganic Chemistry·Matthew A Franzman, Amy M Barrios
Jul 9, 2008·Journal of Medicinal Chemistry·Divya KrishnamurthyAmy M Barrios
Jun 23, 2006·Journal of Medicinal Chemistry·Shamila S Gunatilleke, Amy M Barrios

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.